Compound Interest

Researchers are scouring the ocean for useful microbes that could lead to new medicines, treating the sea as a potential medicine cabinet. Marine microorganisms are seen as a promising source of compounds for drug development, and the search highlights growing interest in ocean biodiversity as a resource for future treatments.

B7-33, a relaxin-family peptide analogue studied for its biased signaling properties, is being highlighted as an example of how biased ligand research is expanding in pharmacology. Researchers interested in compounds that activate beneficial pathways while avoiding unwanted ones are citing B7-33 as a case study in designing drugs with fewer side effects. Discussion centers on its potential in fibrosis and cardiovascular research.

The head of the Environmental Protection Agency visited a Maine company that is developing technology to eliminate PFAS, the so-called forever chemicals linked to health and environmental harm. The visit highlights federal interest in emerging methods for destroying the persistent compounds, which have contaminated water supplies across the US, including in Maine where PFAS spread through sludge-based fertiliser on farmland.

Compound Interest has published a new graphic explaining the chemistry behind sushi, covering what makes sticky rice cling together, how nori seaweed is processed, and the compounds in wasabi and pickled ginger that give them their distinctive flavours and help accompany raw fish. Science communicators are sharing the piece as an accessible food-science explainer.

A Georgia newspaper has published a feature examining TB-500, a synthetic peptide derived from the naturally occurring protein Thymosin Beta-4, and its place in regenerative medicine. The piece explores the science behind the compound and the growing interest in peptide-based approaches to tissue repair and recovery.

A new guide from Nutritional Outlook examines how supplement makers are formulating senolytic products—compounds intended to clear aged, dysfunctional cells linked to aging and chronic disease. The piece walks through current ingredient choices, dosing considerations, and the science behind cellular health claims, arriving as consumer interest in longevity-focused nutrition continues to grow and regulators scrutinize anti-aging claims.

New research indicates that Earth microbes can survive in conditions simulating the environment of Enceladus, Saturn's icy moon, strengthening the case that it could potentially host alien life. Scientists say the findings boost Enceladus's habitability credentials, adding to earlier discoveries of water plumes and organic compounds erupting from beneath its frozen surface.

Drug discovery researchers are being urged to move beyond simple endpoint measurements and gather richer, cell-level data when developing new medicines. The argument is that better-quality information about how drugs act inside cells, rather than simply more data, will improve how promising compounds are identified and developed.

A newly published review examines how traditional Chinese medicine may treat inflammatory bowel disease by targeting the Wnt/β-catenin signalling pathway, a key regulator of intestinal inflammation and repair. The paper outlines the proposed mechanisms of herbal compounds on this pathway and discusses the challenges that remain, including limited clinical evidence and the complexity of the signalling system, before such therapies can enter mainstream use.

A personal finance piece argues that twentysomethings should ditch long goal checklists and focus on just five non-negotiable money habits that compound over time. It contrasts genuine long-term priorities with what it calls 'goals' that exist mainly for social media display. The advice is drawing modest attention among readers interested in simplifying their financial planning.

A new market report outlines the outlook for the data-center AI chips market through 2030, covering market size, compound annual growth rate, key trends, and forecast analysis. The report arrives as demand for AI accelerators continues to drive heavy investment in data-center infrastructure, with industry watchers focused on growth projections and competitive dynamics in the semiconductor sector.